ITMI20041435A1 - Antigeni tumore-specifici generati da splicing alternativo in tumori esprimenti il gene di fusione bcr-abl - Google Patents

Antigeni tumore-specifici generati da splicing alternativo in tumori esprimenti il gene di fusione bcr-abl

Info

Publication number
ITMI20041435A1
ITMI20041435A1 IT001435A ITMI20041435A ITMI20041435A1 IT MI20041435 A1 ITMI20041435 A1 IT MI20041435A1 IT 001435 A IT001435 A IT 001435A IT MI20041435 A ITMI20041435 A IT MI20041435A IT MI20041435 A1 ITMI20041435 A1 IT MI20041435A1
Authority
IT
Italy
Prior art keywords
bcr
abl
tumor
gene
melting
Prior art date
Application number
IT001435A
Other languages
English (en)
Inventor
Vito Michele Fazio
Giuseppe Saglio
Gisella Volpe
Original Assignee
Vito Michele Fazio
Giuseppe Saglio
Gisella Volpe
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vito Michele Fazio, Giuseppe Saglio, Gisella Volpe filed Critical Vito Michele Fazio
Priority to IT001435A priority Critical patent/ITMI20041435A1/it
Publication of ITMI20041435A1 publication Critical patent/ITMI20041435A1/it
Priority to US11/632,275 priority patent/US20080107662A1/en
Priority to EP05770280A priority patent/EP1769076A1/en
Priority to PCT/EP2005/007709 priority patent/WO2006008078A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/32Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
IT001435A 2004-07-16 2004-07-16 Antigeni tumore-specifici generati da splicing alternativo in tumori esprimenti il gene di fusione bcr-abl ITMI20041435A1 (it)

Priority Applications (4)

Application Number Priority Date Filing Date Title
IT001435A ITMI20041435A1 (it) 2004-07-16 2004-07-16 Antigeni tumore-specifici generati da splicing alternativo in tumori esprimenti il gene di fusione bcr-abl
US11/632,275 US20080107662A1 (en) 2004-07-16 2005-07-15 Immunogenic Peptides, Nucleic Acids Encoding The Same And Use Thereof In Cancer Treatment And Diagnosis
EP05770280A EP1769076A1 (en) 2004-07-16 2005-07-15 Immunogenic peptides, nucleic acids encoding the same and use thereof in cancer treatment and diagnosis
PCT/EP2005/007709 WO2006008078A1 (en) 2004-07-16 2005-07-15 Immunogenic peptides, nucleic acids encoding the same and use thereof in cancer treatment and diagnosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT001435A ITMI20041435A1 (it) 2004-07-16 2004-07-16 Antigeni tumore-specifici generati da splicing alternativo in tumori esprimenti il gene di fusione bcr-abl

Publications (1)

Publication Number Publication Date
ITMI20041435A1 true ITMI20041435A1 (it) 2004-10-16

Family

ID=35355527

Family Applications (1)

Application Number Title Priority Date Filing Date
IT001435A ITMI20041435A1 (it) 2004-07-16 2004-07-16 Antigeni tumore-specifici generati da splicing alternativo in tumori esprimenti il gene di fusione bcr-abl

Country Status (4)

Country Link
US (1) US20080107662A1 (it)
EP (1) EP1769076A1 (it)
IT (1) ITMI20041435A1 (it)
WO (1) WO2006008078A1 (it)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2526709B1 (es) * 2013-07-09 2015-10-20 José María PASTRANA ROJAS Dosificador de válvula rotativa
FI124837B (fi) 2013-07-30 2015-02-13 Maricap Oy Menetelmä ja laitteisto jätemateriaalin syöttämiseksi ja käsittelemiseksi
EP4061968A4 (en) * 2019-11-22 2023-12-27 National University of Singapore METHOD AND SYSTEM FOR IDENTIFYING AND VALIDATING COMMON CANDIDATE ANTIGENS AND COMMON ANTIGEN-SPECIFIC T-LYMPHOCYTE PAIRS

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6551795B1 (en) * 1998-02-18 2003-04-22 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to pseudomonas aeruginosa for diagnostics and therapeutics
US6403358B1 (en) * 1999-10-05 2002-06-11 Millennium Pharmaceuticals, Inc. 21529, a novel adenylate cyclase
US20060079493A1 (en) * 2001-03-01 2006-04-13 Lawrence Fritz Methods for treating genetically- defined proliferative disorders with hsp90 inhibitors
WO2004030615A2 (en) * 2002-10-02 2004-04-15 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor

Also Published As

Publication number Publication date
EP1769076A1 (en) 2007-04-04
WO2006008078A1 (en) 2006-01-26
US20080107662A1 (en) 2008-05-08

Similar Documents

Publication Publication Date Title
CY2019041I2 (el) Τροποποιημενα αντισωματα εναντι il-23
CY2020039I1 (el) Νεα anti-cd38 αντισωματα για τη θεραπευτικη αγωγη καρκινου
LTPA2018515I1 (lt) Antagonistiniai IL-17 antikūnai
DK1771482T3 (da) HER2-antistofsammensætning
CY2016030I1 (el) Αντισωματα εναντι της il-17
CY2016023I2 (el) Πρωτεϊνες συνδεσης αντιγονου προς προπρωτεϊνη κονβερτασης σουμπτιλισινης κεχιν τυπου 9 (pcsk9)
DK1599504T3 (da) Modificeret antistof
NL1032236A1 (nl) Glasloos stereoscopisch display.
BRPI0819262A2 (pt) anticorpos monoclonais recombinantes e antìgenos correspondentes para cânceres de cólon e pancreático
ATE358761T1 (de) Rotierender ausbruchsschieber
AU2008225994B2 (en) Monoclonal human tumor-specific antibody
DE602005024689D1 (de) Optisches aufzeichnungsmedium
DK1736159T3 (da) Hudplejemiddel
BRPI0816689A2 (pt) antígenos mutantes gas57 e anticorpos gas57
DE602005019494D1 (de) Optisches Plattenmedium
ITMI20041435A1 (it) Antigeni tumore-specifici generati da splicing alternativo in tumori esprimenti il gene di fusione bcr-abl
DE602005022574D1 (de) Optisches aufzeichnungsmedium
EP1811514A4 (en) OPTICAL INFORMATION MEDIUM
DE602005013471D1 (de) Optisches Aufzeichnungsmedium
DE602005020316D1 (de) Optisches aufzeichnungsmedium
DE602005011187D1 (de) Optische Synchronisiereinrichtung
UA11752S (uk) Фотоальбом
GB0407587D0 (en) Cancer associated antigens
ITNA20050025A1 (it) Procedimento di assemblaggio di album fotografici
NL1025360A1 (nl) Warmtelasbaar reflectiemateriaal.